69 results
Page 2 of 4
8-K/A
oc1aw01agaz942
16 Nov 21
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
kbrl6h
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
DEF 14A
7o7p7xioexhvyjh rp
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
7zl4fi
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
1u5w47
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
ujtl4okrxvy8wag2
24 Sep 21
Annual report
7:31am
424B3
rdt07bp9kj2znjsyig63
22 Jul 21
Prospectus supplement
10:27am
424B3
bigj52urua6zqzkj1
16 Mar 21
Prospectus supplement
12:00am
S-8
EX-4.2
9ws6dvxrcup415sfo
5 Mar 21
Registration of securities for employees
12:54pm
10-Q
EX-3.1
psf urzqyj78j4
17 Dec 20
Quarterly report
12:00am
424B4
fz930ehp
13 Nov 20
Prospectus supplement with pricing info
8:52pm